These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22687143)

  • 21. Malnutrition and neuropsychiatric symptoms in dementia: the Cache County Dementia Progression Study.
    Kauzor K; Drewel M; Gonzalez H; Rattinger GB; Hammond AG; Wengreen H; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2023 Nov; 35(11):653-663. PubMed ID: 37246509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis.
    Chandler J; Georgieva M; Desai U; Done N; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):320-328. PubMed ID: 38374738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis.
    Edwin TH; Strand BH; Persson K; Engedal K; Selbæk G; Knapskog AB
    Int Psychogeriatr; 2021 Aug; 33(8):779-789. PubMed ID: 33213607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study.
    Lyketsos CG; Toone L; Tschanz J; Rabins PV; Steinberg M; Onyike CU; Corcoran C; Norton M; Zandi P; Breitner JC; Welsh-Bohmer K; Anthony J; Østbye T; Bigler E; Pieper C; Burke J; Plassman B; Green RC; Steffens DC; Klein L; Leslie C; Townsend JJ; Wyse BW; Munger R; Williams M;
    Am J Geriatr Psychiatry; 2005 Aug; 13(8):656-64. PubMed ID: 16085781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: the Cache County Dementia Progression Study.
    Gilbert M; Snyder C; Corcoran C; Norton MC; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2014 Oct; 26(10):1593-601. PubMed ID: 24831798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
    McDougall F; Edgar C; Mertes M; Delmar P; Fontoura P; Abi-Saab D; Lansdall CJ; Boada M; Doody R
    J Prev Alzheimers Dis; 2021; 8(2):151-160. PubMed ID: 33569561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of quality of life ratings for persons with dementia simultaneously reported by patients and their caregivers: the Cache County (Utah) Study.
    Buckley T; Fauth EB; Morrison A; Tschanz J; Rabins PV; Piercy KW; Norton M; Lyketsos CG
    Int Psychogeriatr; 2012 Jul; 24(7):1094-102. PubMed ID: 22414494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    Defrancesco M; Marksteiner J; Kemmler G; Dal-Bianco P; Ransmayr G; Benke T; Mosbacher J; Höller Y; Schmidt R
    J Alzheimers Dis; 2020; 73(1):125-133. PubMed ID: 31744004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.
    Hsu JL; Lee WJ; Liao YC; Wang SJ; Fuh JL
    Alzheimers Res Ther; 2017 Nov; 9(1):91. PubMed ID: 29169407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study.
    Agüera-Ortiz L; Frank-García A; Gil P; Moreno A;
    Int Psychogeriatr; 2010 Dec; 22(8):1265-79. PubMed ID: 20849672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study.
    Treiber KA; Carlson MC; Corcoran C; Norton MC; Breitner JC; Piercy KW; Deberard MS; Stein D; Foley B; Welsh-Bohmer KA; Frye A; Lyketsos CG; Tschanz JT
    J Gerontol B Psychol Sci Soc Sci; 2011 Jul; 66(4):416-25. PubMed ID: 21441386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
    Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M
    Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    Scheltens NME; Tijms BM; Heymans MW; Rabinovici GD; Cohn-Sheehy BI; Miller BL; Kramer JH; Wolfsgruber S; Wagner M; Kornhuber J; Peters O; Scheltens P; van der Flier WM;
    J Alzheimers Dis; 2018; 65(3):1029-1039. PubMed ID: 30103316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.
    Mielke MM; Okonkwo OC; Oishi K; Mori S; Tighe S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
    Alzheimers Dement; 2012; 8(2):105-13. PubMed ID: 22404852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia severity and the longitudinal costs of informal care in the Cache County population.
    Rattinger GB; Schwartz S; Mullins CD; Corcoran C; Zuckerman IH; Sanders C; Norton MC; Fauth EB; Leoutsakos JM; Lyketsos CG; Tschanz JT
    Alzheimers Dement; 2015 Aug; 11(8):946-54. PubMed ID: 25614127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.